Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Find weekend side hustles that pay well while offering the flexibility you need. These gigs can significantly boost your income.
19,264 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Meta unveils Muse Spark 1.1, touting stronger coding and multimodal abilities as it accelerates its AI push led by Al...
As 2026 unfolds, investors face a choice between StubHub's fast-growing digital ticketing platform and Build-A-Bear's...
Nuclear expansion plans are accelerating, and uranium ETFs are drawing fresh attention. A look at URA, URNM, URNJ, NL...
A late-night interview about a political candidate sparked a broader discussion on broadcast rules and money. This ar...
Investors want to know if now is the time figma stock? This guide breaks down how to evaluate Figma stock, what metri...
Micron Technology and SanDisk shares tumbled in early trading as energy-price volatility tests cost structures at glo...
As Washington rejects a retail CBDC on paper, a private-dollar regime gains power with transfer controls. The questio...
Two established players collide in a market shaped by AI data-center demand and inventory normalization. Microchip Te...
A top OpenAI cofounder reveals he hasn’t written code for months, signaling a shift toward agentic AI and raising que...
Geopolitics just accelerated volatility in energy markets. The rejection of a ceasefire proposal by iran has traders ...
The New York Fed reports 9.7% of student loan balances are 90+ days delinquent in Q1 2026, signaling rising retiremen...